ELISA measurements from plasma samples were carried out using the Ciraplex® platform (Aushon Biosystems, Billerica, MA, US). Commercial assays were purchased and measurements were carried out accordin
This study aims to introduce a new index that could become a framework for future modification and improvement, and retrospectively test the predictability of this index collectively and individually
